Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture
Guest Editor:
Jan Thirkettle, Chief Executive Officer at Transine Therapeutics
Jan Thirkettle
Chief Executive Officer at Transine Therapeutics
September 2020
Sponsors
Download full spotlight
TESSA technology: a new paradigm in AAV manufacturing
R Cawood
1 October 2020
FastFacts
Read more
Scalable and efficient AAV production process with new Fibro chromatography technology
L Adamson-Small,
M Lundgren,
P Guterstam
30 September 2020
Innovator Insight
Read more
Delivering cell and gene therapies: evolving logistics considerations
A Lee-Mohan,
D Murphy
29 September 2020
Interview
Read more
A necessary transition: why viral vector production for gene therapy needs to evolve
R Cawood
29 September 2020
Interview
Read more
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them
H Brahmbhatt,
T Guarinoni,
E Simmons
29 September 2020
Expert Roundtable
Read more
Delivering cell and gene therapies: evolving logistics considerations - Podcast
A Lee-Mohan,
D Murphy
29 September 2020
Podcast
Listen now
Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture
J Thirkettle
29 September 2020
Foreword
Read more
The power of small: success of small academic/healthcare units within the cell & gene therapy industry
B Weil,
O Bain
24 September 2020
Commentary
Read more
Driving NK cell therapy manufacture to commercial scale
L Sender
23 September 2020
Interview
Read more
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them
H Brahmbhatt,
T Guarinoni,
E Simmons
21 September 2020
Expert Roundtable Video
Watch now
Small labels, big challenges: solutions for advanced therapy labeling
H Hagen,
C Suchet
21 September 2020
Commentary
Read more
Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools
A Katragadda,
I Karimi,
X Wang
3 September 2020
Expert Insight
Read more
The multi-modal manufacturing movement - you don't need to know the future to be ready for it
Peter Walters, ATMP Conceptual Designer at CRB
Noel Maestre, Director, ATMP at CRB
30 September 2020
Webinar
Watch now
Get your assay in gear – removing analytical bottlenecks on the path to clinical readiness
Ian Gaudet, Senior Director of Process Sciences at Miltenyi Biotec
8 September 2020
Webinar
Watch now
Realizing flexible automation – Closing gaps to meet industry needs
Knut Niss, CTO at Mustang Bio, Inc.
Steven Thompson, Director, Sales & Product Management at Sexton Biotechnologies
Mark Lowdell, Professor of Cell & Tissue Therapy at Royal Free London NHS Foundation Trust
12 August 2020
Webinar
Watch now
Size matters: ensuring donor pool sustainability and cell therapy supply chain success when scaling up and out
Chris Learn, Senior Director - Therapeutic Strategy Lead, Cell & Gene Therapy at IQVIA
Amit Agarwal, Managing Director at Deloitte Consulting
Raymond Hornung, Senior Manager, Logistics at Be The Match BioTherapies
6 August 2020
Webinar
Watch now
Scalable and efficient AAV production process with new Fibro chromatography technology
Laura Adamson-Small, Upstream & Analytical Development Lead, AAV Process Development at UCB Pharma
Mats Lundgren, Customer Applications Director, Life Sciences, Cytiva
Peter Guterstam, Product Manager, Next Generation Resins & Technologies, Cytiva
30 July 2020
Webinar
Watch now
×
Please enter your email to register
Register